A	B	C	D	E	F	G	H	I	J	K	L	M
1
2		Brand	Indication	MOA	Approved	Economics	IP				Price	109.54
3		Ingrezza (valbenazine)	TD	VMAT2	4/11/2017	Mitsubishi Tanabe in Japan					Shares	95.639321	Q222
4		Ongentys (opicapone)	Parkinson's								MC	10476.33122234
5					Phase						Cash	1137.3	Q222
6		NBI-1117568	Schizophrenia	M4 agonist	I	Sosei					Debt	169	Q222
7		NBI-827104	Epilepsy	T-type Ca channel blocker	II	IDIA					EV	9508.031222340001
8		NBI-1070770	Psychiatric		I
9		crinecerfont	CAH	CRF1 antagonist	III						CEO	Kevin Gorman
10		NBI-1065846	MDD	GPR139 agonist	II	TAK
11		NBI-1065845	MDD	AMPA	II	TAK
12		NBI-921352	Epilepsy	Nav1.6	II	XENE
13
14
15						12/6/22: NBI-827104 "STEAMBOAT" study fails